| News

ATAMYO THERAPEUTICS: THE NEW WEBSITE IS NOW ONLINE

The Atamyo Therapeutics website is now accessible! Atamyo's mission is to provide a new generation of quality gene therapies for patients with neuromuscular diseases.

 
Currently, the pipeline focuses on 5 subtypes of LGMD:
- LGMD-R9 / LGMD2I
- LGMD-R5 / LGMD2C
- LGMD-R1 / LGMD2A
- LGMD-R2 / LGMD2B
- LGMD-R3 / LGMD2D
 
Here the Atamyo website:    https://atamyo.com

©2020 GFBONLUS.IT - GRUPPO FAMILIARI BETA-SARCOGLICANOPATIE
+39 328 0075986 This email address is being protected from spambots. You need JavaScript enabled to view it.

Via Civasca 112 23018 Talamona - SO  Italia

Made by Betsoft

Sign Up Today!

Sign up to be included in the GFB Lgmd Patient Network where you will receive cutting edge research updates from the leading experts in the world and also be invited to hear about new clinical trials.
Anyone can join the GFB Lgmd Patient Network.
 
Sign Up